At a moment when money is flowing out of life sciences venture investing, three Boston venture capital firms are building companies that seek to improve the odds for in vitro fertilization, sequence the genomes of tumors to identify the best drugs to attack them, or regrow hair on balding pates. They’re reading journals and interviewing researchers to find promising scraps of science, and then they are assigning SWAT teams of executives to try to build businesses around that germ of an idea
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help